136 related articles for article (PubMed ID: 7809465)
1. [Prolymphocytic leukemia: the therapeutic strategy].
Fava S; De Paoli A; Grimi E; Luoni M; Tocci A; Tosi A; Cassi E
Recenti Prog Med; 1994 Oct; 85(10):496-501. PubMed ID: 7809465
[TBL] [Abstract][Full Text] [Related]
2. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
4. Current treatment options in prolymphocytic leukemia.
Robak T; Robak P
Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
[TBL] [Abstract][Full Text] [Related]
5. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
7. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
Shvidel L; Shtalrid M; Bassous L; Klepfish A; Vorst E; Berrebi A
Leuk Lymphoma; 1999 Mar; 33(1-2):169-79. PubMed ID: 10194135
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
9. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities.
Yokohama A; Karasawa M; Takada S; Matsushima T; Murakami H; Miyao S; Sato S; Naruse T
J Med; 2000; 31(3-4):183-94. PubMed ID: 11280450
[TBL] [Abstract][Full Text] [Related]
11. [Prolymphocytic B-cell leukemia with fatal acute liver failure. A case report].
Steidl L; Rossi A; Cornaggia M; Crippa G; Venco A
Recenti Prog Med; 1994 Mar; 85(3):186-9. PubMed ID: 8184202
[TBL] [Abstract][Full Text] [Related]
12. Prolymphocytic leukaemia.
Catovsky D
Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
[TBL] [Abstract][Full Text] [Related]
13. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
14. Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia.
Crisostomo RH; Fernandez JA; Caceres W
Leuk Res; 2007 May; 31(5):699-701. PubMed ID: 16997373
[TBL] [Abstract][Full Text] [Related]
15. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958
[TBL] [Abstract][Full Text] [Related]
16. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
[TBL] [Abstract][Full Text] [Related]
17. Management of chronic lymphocytic leukaemia.
Kalil N; Cheson BD
Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Montillo M; Tedeschi A; O'Brien S; Di Raimondo F; Lerner S; Ferrajoli A; Morra E; Keating MJ
Cancer; 2003 Jan; 97(1):114-20. PubMed ID: 12491512
[TBL] [Abstract][Full Text] [Related]
19. T-small lymphocyte disorders.
Bartlett NL; Longo DL
Semin Hematol; 1999 Apr; 36(2):164-70. PubMed ID: 10319385
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]